GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (TSXV:LXG.H) » Definitions » Operating Margin %

Lexagene Holdings (TSXV:LXG.H) Operating Margin % : -3,853.45% (As of Nov. 2022)


View and export this data going back to 2007. Start your Free Trial

What is Lexagene Holdings Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Lexagene Holdings's Operating Income for the three months ended in Nov. 2022 was C$-2.24 Mil. Lexagene Holdings's Revenue for the three months ended in Nov. 2022 was C$0.06 Mil. Therefore, Lexagene Holdings's Operating Margin % for the quarter that ended in Nov. 2022 was -3,853.45%.

The historical rank and industry rank for Lexagene Holdings's Operating Margin % or its related term are showing as below:


TSXV:LXG.H's Operating Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.63
* Ranked among companies with meaningful Operating Margin % only.

Lexagene Holdings's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Lexagene Holdings's Operating Income for the three months ended in Nov. 2022 was C$-2.24 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Nov. 2022 was C$-10.49 Mil.


Lexagene Holdings Operating Margin % Historical Data

The historical data trend for Lexagene Holdings's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings Operating Margin % Chart

Lexagene Holdings Annual Data
Trend Mar13 Mar14 Mar15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -16,840.54 -14,138.95

Lexagene Holdings Quarterly Data
Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5,615.00 16,072.22 -14,184.21 -3,374.68 -3,853.45

Competitive Comparison of Lexagene Holdings's Operating Margin %

For the Medical Devices subindustry, Lexagene Holdings's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lexagene Holdings's Operating Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's Operating Margin % falls into.



Lexagene Holdings Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Lexagene Holdings's Operating Margin % for the fiscal year that ended in Feb. 2022 is calculated as

Operating Margin %=Operating Income (A: Feb. 2022 ) / Revenue (A: Feb. 2022 )
=-13.432 / 0.095
=-14,138.95 %

Lexagene Holdings's Operating Margin % for the quarter that ended in Nov. 2022 is calculated as

Operating Margin %=Operating Income (Q: Nov. 2022 ) / Revenue (Q: Nov. 2022 )
=-2.235 / 0.058
=-3,853.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lexagene Holdings  (TSXV:LXG.H) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Lexagene Holdings Operating Margin % Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Lexagene Holdings (TSXV:LXG.H) Business Description

Traded in Other Exchanges
N/A
Address
500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915
Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.

Lexagene Holdings (TSXV:LXG.H) Headlines

No Headlines